Healthcare - Biotechnology - NASDAQ - US
$ 6.96
-12.1 %
$ 216 M
Market Cap
-2.56
P/E
Price Target
Average
232.06%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
23.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Acrivon Therapeutics, Inc. Common Stock
Wall Street analysts predict an average 1-year price target for ACRV of $23.1 , with forecasts ranging from a low of $17 to a high of $30 .
ACRV Lowest Price Target
Wall Street Target
17 USD
144.25%
ACRV Average Price Target
Wall Street Target
23.1 USD
232.06%
ACRV Highest Price Target
Wall Street Target
30 USD
331.03%
REVENUE FORECAST
Revenue Forecast Chart ACRV
EBIT FORECAST
EBIT Forecast Chart ACRV
NET INCOME FORECAST
Net Income Chart ACRV